Beneficient Completes $4M Convertible Note Financing with Second $1.8M Tranche
BENF sits 27% above its 52-week low of $2.158 on elevated volume (1.9× avg).
Summary
Beneficient drew the second $1.8 million tranche of its $4.0 million convertible note facility with Yorkville, completing the program. The notes carry a variable conversion price as low as $0.89, creating substantial dilution risk for a company already in financial distress.
Key Events · Financing and Capital Events · BENF
-
Second Convertible Note Tranche Issued
On August 5, 2026, Beneficient issued a second $2.0 million convertible promissory note to Yorkville, with net proceeds of approximately $1.8 million after a 5% original issue discount. This completes the $4.0 million commitment under the amended SEPA.
-
Highly Dilutive Conversion Terms
The notes convert at the lower of $5.6064 or 92% of the lowest VWAP over five trading days, with a floor of $0.89 per share. At the current stock price of $2.75, the variable conversion price could be as low as $0.89, implying up to 4.7 million shares could be issued — over 10% of the current market cap.
-
Financial Distress Context
The company faces a going concern warning, an $87.4 million annual net loss, defaulted debt, and a $67.9 million arbitration award. This financing provides short-term liquidity but underscores the company's precarious financial position.
-
Maturity and Interest Rate
The notes mature on June 30, 2027, and bear interest at 5.0% per annum, increasing to 18.0% upon an event of default. The maximum share issuance cap of 4,719,101 assumes interest at 5% through maturity.
Analysis · BENF · Finance
Beneficient has now drawn the full $4.0 million available under its amended standby equity purchase agreement with Yorkville, issuing a second $2.0 million convertible promissory note (net proceeds ~$1.8 million) on August 5, 2026. This follows the first $1.8 million tranche in early July. The notes are convertible at the lower of $5.6064 or 92% of the lowest VWAP over five days, with a floor of $0.89 — a deeply dilutive structure given the current stock price of $2.75. The maximum share issuance upon conversion is capped at 4.7 million shares, representing significant potential dilution for a company with a market cap of only $42 million. Against the backdrop of a going concern warning, massive losses, and defaulted debt, this financing provides critical near-term liquidity but at a steep cost to existing shareholders.
At the time of this filing, BENF was trading at $2.75 on NASDAQ in the Finance sector, with a market capitalization of approximately $42.4M. The 52-week trading range was $2.16 to $12.48. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.